Monographie - Amoxicillin sodium

Son güncelleme :
19/11/2024

Amoxicillin sodium

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfoxil	Türkiye
Allmox	Hindistan
Amitron	İspanya
Amocillin	Güney Afrika Cumhuriyeti
Amodex	Fas
Amofluxin	Mısır
Amoxicilin	Büyük Britanya, Peru
Amoxicillina	İtalya
Amoxidal	Arjantin, Peru
Amoxil	Avustralya, Büyük Britanya, Fas, İrlanda, Mısır, Portekiz, Suudi Arabistan, Tunus, Yunanistan
Aximycine	Fas, Tunus
Bactox	Fas, Fransa
Biomox	Mısır
Clamoxyl	Belçika, Fas, Fransa, Hollanda, İspanya, İsviçre, Lüksemburg
Darzitil	Arjantin
E-Mox	Mısır
Farconcil	Mısır
Fisamox	Avustralya
Flemoxin	Hollanda
Glymox Plus	Hindistan
Ibiamox	İtalya, yeni Zelanda
Klomox	Hindistan
Largopen	Türkiye
Magcil	Hindistan
Mixcilin	Arjantin
Moxacin	Avustralya
Moxilen	Tunus
Moxynil	Mısır
Novabritine	Lüksemburg
Pamocil	İtalya
Penamox	Fas, Meksika
Simplamox	İtalya
Velamox	İtalya

Kaynaklar : Amoxicillin sodium

	tip	yayın
186	Dergi	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
427	Dergi	Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB. Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Am J Hosp Pharm 1986 ; 43: 3027-3030.
598	Dergi	Mc Donald C, Sunderland VB, Lau H, Shija R. The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states. J Clin Pharm Ther 1989 ; 14: 45-52.
889	Dergi	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
939	Dergi	Gilbar PJ, Groves CF. Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Aust J Hosp Pharm 1994 ; 24: 167-170.
1333	Dergi	Cook B, Hill SA, Lynn B. The stability of amoxycillin sodium in intravenous infusion fluids. J Clin Hosp Pharm 1982 ; 7: 245-250.
1357	Dergi	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1845	Dergi	Müller HJ, Haker I. The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container). EJHP 2003 ; 6: 106-111.
1888	Dergi	Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A. Compatibility study of midazolam. Ziekenhuisfarmacie 1986 ; 2: 45-48.
2349	Dergi	Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B. Incompatibility of imipenem–cilastatin and amoxicillin Am J Health-Syst Pharm 2009 ; 66: 1253-1254.
3227	Dergi	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laboratuar	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3527	Laboratuar	Amoxicillin (Amoxil®) – Summary of Product Characteristics Glaxo Smith Kline 2018
3529	Laboratuar	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3549	Laboratuar	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratuar	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratuar	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratuar	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3728	Dergi	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3777	Dergi	Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D. Stability of ampicillin and amoxicillin in peritoneal dialysis solutions Am J Health-Syst Pharm 2015 ; 72:13-14
4211	Dergi	Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A. Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps. PlosOne 2019
4254	Dergi	D'Huart E, Vigneron J, Demoré B. Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4634	Dergi	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4654	afiş	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021
4837	Dergi	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales